Liquid biopsy performed on serum samples taken from breast cancer patients can provide increasingly accurate information on cancer progression and enable earlier detection of cancer recurrence, a new study from the University of Eastern Finland and Kuopio University Hospital shows.

On March 23, after review by the State Food and Drug Administration, two COVID-19 antigen detection reagent products were approved. As of March 23, the State Food and Drug Administration has approved 19 new coronavirus antigen detection reagent products.

The US Food and Drug Administration this week granted separate Emergency Use Authorizations for three direct-to-consumer SARS-CoV-2 tests from Quest Diagnostics, as well as a home sample collection kit for use with the tests.

According to the information of the official website China Food and Drug Administration, in March 18th, the 3 Shanghai COVID-19 antigen detection reagent products were approved.Up to now, China Food and Drug Administration has approved 17 COVID-19 antigen detection reagents.

On March 17th, NMPA has approved the 14th New Coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) produced by Zybio. Up to now, 14 COVID-19 antigen detection kits have been approved for sale.

Jilin Province has ordered 12 million antigen detection reagents nationwide in a short period of time, some have been delivered.

AnchorDx, a world-leading developer of cancer screening and early detection solutions, is delighted to announce that Dr. Marina Bibikova has come on board as Chief Scientific Officer (CSO).

Type 1 Diabetes Mellitus (T1DM) is an autoimmune disease that occurs due to destruction of the islets of Langerhans in the pancreas. These islets contain β cells and when destroyed, it reduces the body’s ability to produce insulin leading to hyperglycemia.

Investigators have determined that high-risk HPV DNA can be detected in saliva in most patients with HPV-driven oropharyngeal cancers at the time of diagnosis.

A large international collaboration led by researchers from the Johns Hopkins Kimmel Cancer Center has identified promising new targets for pancreatic cancer treatment and early diagnosis after examining various aspects of these tumors' genes and proteins.